Navigation Links
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
Date:5/15/2012

athway for GEP-NETs 23Figure 4: Neuroendocrine Carcinoma Therapeutics Market, Seven Major Markets, Revenue ($m), 2006-2011 25Figure 5:Neuroendocrine Carcinoma Therapeutics , Market Share (%), 2011 26Figure 6: Neuroendocrine Carcinoma Therapeutics Market, Seven Major Markets, Forecast ($m), 2011-2019 27Figure 7:Neuroendocrine Carcinoma Therapeutics, Market Share (%), 2019 28Figure 8:Neuroendocrine Carcinoma Therapeutics Market, the US, Revenue ($m), 2006-2011 29Figure 9: Neuroendocrine Carcinoma Therapeutics Market, the US, Market Forecast ($m), 2011-2019 30Figure 10:Neuroendocrine Carcinoma Therapeutics Market, the UK, Revenue ($m), 2006-2011 31Figure 11: Neuroendocrine Carcinoma Therapeutics Market, the UK, Market Forecast ($m), 2011-2019 32Figure 12:Neuroendocrine Carcinoma Therapeutics Market, France, Revenue ($m), 2006-2011 33Figure 13: Neuroendocrine Carcinoma Therapeutics Market, France, Market Forecast ($m), 2011-2019 34Figure 14:Neuroendocrine Carcinoma Therapeutics Market, Germany, Revenue ($m), 2006-2011 35Figure 15: Neuroendocrine Carcinoma Therapeutics Market, Germany, Market Forecast ($m), 2011-2019 36Figure 16:Neuroendocrine Carcinoma Therapeutics Market, Italy, Revenue ($m), 2006-2011 37Figure 17: Neuroendocrine Carcinoma Therapeutics Market, Italy, Market Forecast ($m), 2011-2019 38Figure 18:Neuroendocrine Carcinoma Therapeutics Market, Spain, Revenue ($m), 2006-2011 39Figure 19: Neuroendocrine Carcinoma Therapeutics Market, Spain, Market Forecast ($m), 2011-2019 40Figure 20:Neuroendocrine Carcinoma Therapeutics Market, Japan, Revenue ($m), 2006-2011 41Figure 21: Neuroendocrine Carcinoma Therapeutics Market, Japan, Market Forecast ($m), 2011-2019 42Figure 22:Neuroendocrine Carcinoma Therapeutics – Drivers and Barriers, 2012 44Figure 23:Opportunities and Unmet Need in the GI Carcinoid NETs Therapeutics Market 45Figure 24:Opportunities and Unmet Need in Pancreatic NETs Therapeutics Market 46Figure 25: Strategic Competitor Assessment of the Major
'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
2. Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors
3. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
4. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
5. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
6. Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma
7. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Proove ... medicine, will be exhibiting data and research conducted through ... International Spine Intervention Society’s (ISIS) 22nd Annual Scientific ... at the Hyatt Regency, in Orlando, Florida. ... and clinical competence of physicians who care for patients ...
(Date:7/28/2014)... 2014 Immunomic Therapeutics, Inc. (ITI) has ... develop potential treatments for glioblastoma multiforme (GBM), the most ... their patented vaccine platform, LAMP-vax. , The agreements, ... on the work of John H. Sampson, MD, PhD, ... Robert Tisch Brain Tumor Center at Duke University Medical ...
(Date:7/28/2014)... 2014  InterMune, Inc. (NASDAQ: ITMN ) ... 2014 financial results at the close of the U.S. ... and webcast will be hosted by InterMune at 4:30 ... investors and others may participate in the conference call ... ID#21728775. A replay of the webcast and teleconference will be ...
(Date:7/25/2014)... July 26, 2014 "Ischemic Stroke ... 2014" provides data on the Ischemic Stroke and ... elemental information and data relating to the clinical ... View full global Ischemic Stroke Research Report 2014 ... overview of the trial numbers and their recruitment ...
Breaking Biology Technology:Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3
... Fang-Fang Wu, Xuemei He, and David R Nau, Bio-Rad Laboratories, Inc., ... Introduction , ... that can be used for the efficient purification ... variety of expression systems. , The synthesis of IMAC ...
... , , ... is one of the key regulatory enzymes , of ... of phosphoenolpyruvate (PEP) to pyruvate and the phosphorylation of ADP , ... aerobic and anaerobic energy metabolism , in invertebrates, regulation ...
... important intracellular signals involved in the, ... factors.The discovery of a phosphatidylinositol, ... the inositol ring uncovered a new pathway ... Phosphoinositide 3-kinase has been purified to, ...
Cached Biology Technology:Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 2Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 3Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 4Purification of Two Isoforms of Pyruvate Kinase from Nordic Krill Using an UNO Q1 Column, Rev A 2Purification of Phosphoinositide 3-Kinase With UNO Columns 2
(Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
(Date:7/28/2014)... identified areas of the Earth that are high priorities ... Europe is particularly vulnerable, as it has the lowest ... of any continent in ,refugia, areas of biological ... remain relatively constant during times of great environmental change. ... in Scandinavia and Scotland. , The biggest refugia ...
(Date:7/28/2014)... Rice University researchers are using magnetic beads and DNA ... be used as microscale models for polymer macromolecules. , ... as theory in the 1950s, can be made as ... of interest to materials scientists who study the basic ... chemical and biomolecular engineer Sibani Lisa Biswal and graduate ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2Seeing is bead-lieving 2
... and Drug Administration approved a drug called BiDil as ... claiming in a press release that this was a ... Science, Politics and Big Business Re-create Race in the ... Kirkland & Ellis Professor at Northwestern University School of ...
... responses are some of the most studied behaviors by ... sensory information. The ability to evade predators plays a ... explore their environment to find food, find mates and ... to avoid predators, thereby increasing their chances for survival. ...
... over Niagara Falls. Pollution from fires in Ontario, Canada ... being measured by NASA,s Aqua satellite. One instrument ... two views of the pollution from the fires in ... flies onboard NASA,s Aqua and Terra satellites. MODIS has ...
Cached Biology News:Divided by race 2Elusive prey 2NASA measures wildfire pollution pour over Niagara Falls 2
...
...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Biology Products: